We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 86,736

The Need to Reduce Unnecessary Medicare Opioid Prescribing
  • Manatt Phelps & Phillips LLP
  • USA
  • October 23 2018

Many older adults are caught up in the nation’s opioid epidemic. From 2002 to 2014, opioid misuse doubled among Americans ages 50 and older. Experts


Supreme Court Declines to Provide Guidance on FCA Pleading Requirements
  • Manatt Phelps & Phillips LLP
  • USA
  • October 23 2018

On October 1, 2018, the U.S. Supreme Court denied a petition for a writ of certiorari asking the Court to weigh in on just how precisely a


Vertical Mergers: A Road Map for Success in Healthcare Consolidation
  • Manatt Phelps & Phillips LLP
  • USA
  • October 23 2018

Over the last month, the Department of Justice Antitrust Division (DOJ) cleared Cigna Corp.’s $67 billion acquisition of Express Scripts Holding Co


5 Key Takeaways: How Do We Ensure Effective Protection of Antibodies?
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • October 23 2018

As part of the Life Sciences Patent Network's 2018 NORTH AMERICA-FALL Conference, Chemistry & Life Sciences Associate Yifan Mao led a roundtable


Care homes briefing 183 - Competitions and Markets Authority advice on charging fees after death
  • RadcliffesLeBrasseur
  • United Kingdom
  • October 23 2018

On 31 May 2018 the Competition and Markets Authority (CMA) published guidance on the charging of fees after a resident’s death and the treatment of


The Health Information and Quality Authority (“HIQA”) issues guidance on a data quality framework for health and social care
  • McDowell Purcell
  • Ireland
  • October 23 2018

On 17 October 2018, HIQA published its guidance on a 'Data Quality Framework for Health and Social Care' (the "Guidance"). The Guidance applies


Employer’s Duty to Accommodate High Risk Pregnancies
  • Seyfarth Shaw LLP
  • USA
  • October 23 2018

Earlier this month, Plaintiff Caroline Ruiz filed suit in the Southern District of New York against her former employer New Avon LLC, contending that


Recent FDA Enforcement Letters Lay Out Roadmap for Future Scrutiny of Efficacy Claims
  • Sidley Austin LLP
  • USA
  • October 23 2018

The U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) recently released the third untitled letter in 2018 to


春风先发苑中梅国家健康医疗大数据标准安全和服务管理办法试行 解读及启示
  • King & Wood Mallesons
  • China
  • October 23 2018

互联网时代大数据已成为耳熟能详的时髦词汇大数据分析和应用技术的蓬勃发展逐渐赋予数据实际的“生产力”在此背景下国家卫生健康委员会下称“卫


FDA Responds to Device Software Vulnerabilities by Releasing New Draft Cybersecurity Guidance
  • Mintz
  • USA
  • October 22 2018

On October 18, 2018, FDA released a new draft guidance, Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, which